Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care

ABSTRACT This analysis provides guidelines for the proper use of topical ophthalmic nonsteroidal anti-inflammatory drugs (NSAIDs), discusses their effect on inflammation, and their role in the prevention of cystoid macular edema (CME). A novel treatment strategy is presented for recommended topical ophthalmic NSAID dosing in patient populations based on risk factors for CME. The article reviews current topical ophthalmic NSAIDs, as well as a newest generation of pro‐drug NSAIDs. In addition, combination therapy of NSAIDs and corticosteroids are discussed, along with a general review of therapeutic guidelines for dosing regimens, and benefits and risks of therapy. The goal of this analysis is to provide a suggested therapeutic regimen with topical NSAIDs to assist in achieving optimal clinical and functional outcomes.

[1]  G. Krapohl,et al.  Nonsteroidal Anti-Inflammatory Drugs , 2019, CRC Handbook of Ototoxicity.

[2]  R. Rice,et al.  Ocular Effects of Nepafenac Ophthalmic Suspension Following Six Months of Topical Ocular Administration to Pigmented Rabbits , 2005 .

[3]  R. Munger,et al.  Ocular Effects of Nepafenac Ophthalmic Suspension Following Three Months of Topical Ocular Administration to Cynomolgus Monkeys , 2005 .

[4]  S. Mohr,et al.  Topical Administration of Nepafenac Inhibits the Early Stages of Diabetic Retinopathy , 2005 .

[5]  J. Penn,et al.  Nepafenac Metabolite, Amfenac, Inhibits VEGF Induced Phosphorylation of ERK in Human Retinal Microvascular Endothelial Cells , 2005 .

[6]  R. Rice,et al.  Ocular Effects of Nepafenac Ophthalmic Suspension in New Zealand White Rabbits Undergoing Partial Corneal Incisions , 2005 .

[7]  P. Williams,et al.  Comparison of topical steroids for acute anterior uveitis. , 2004, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[8]  T. O'brien,et al.  Effects of topical nonsteroidal antiinflammatory drugs on the expression of matrix metalloproteinases in the cornea. , 2004, Journal of cataract and refractive surgery.

[9]  D. S. Rho.  Treatment of acute pseudophakic cystoid macular edema: Diclofenac versus ketorolac , 2003, Journal of cataract and refractive surgery.

[10]  J. Flanagan,et al.  Inflammation-Mediated Retinal Edema in the Rabbit Is Inhibited by Topical Nepafenac , 2003, Inflammation.

[11]  P. McDonnell,et al.  Histopathology of corneal melting associated with diclofenac use after refractive surgery , 2003, Journal of cataract and refractive surgery.

[12]  A. Martidis,et al.  Managing cystoid macular edema after cataract surgery , 2003, Current opinion in ophthalmology.

[13]  F. Sauerburger,et al.  The role of matrix metalloproteinases in ulcerative keratolysis associated with perioperative diclofenac use. , 2001, Ophthalmology.

[14]  N. Congdon,et al.  Corneal complications associated with topical ophthalmic use of nonsteroidal antiinflammatory drugs , 2001, Journal of cataract and refractive surgery.

[15]  K. Solomon,et al.  Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery. , 2001, Ophthalmology.

[16]  W. Baumann,et al.  Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. , 2000, Ophthalmology.

[17]  J. Yanni,et al.  Nepafenac, a Unique Nonsteroidal Prodrug with Potential Utility in the Treatment of Trauma-Induced Ocular Inflammation: II. In Vitro Bioactivation and Permeation of External Ocular Barriers , 2000, Inflammation.

[18]  J. Yanni,et al.  Nepafenac, a Unique Nonsteroidal Prodrug with Potential Utility in the Treatment of Trauma-Induced Ocular Inflammation: I. Assessment of Anti-Inflammatory Efficacy , 2000, Inflammation.

[19]  J. Schwiegerling,et al.  Acular as a single agent for use as an antimiotic and anti-inflammatory in cataract surgery. , 2000, Journal of cataract and refractive surgery.

[20]  N. Bressler,et al.  Ketorolac treatment of pseudophakic cystoid macular edema identified more than 24 months after cataract extraction. , 1999, Ophthalmology.

[21]  J. Jenkins,et al.  Comparison of the efficacy and safety of ketorolac tromethamine 0.5% and prednisolone acetate 1% after cataract surgery. , 1999, Journal of cataract and refractive surgery.

[22]  J. Cheetham,et al.  Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery. , 1999, Clinical therapeutics.

[23]  A. Flach,et al.  Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery. , 1998, Ophthalmology.

[24]  A. Chuang,et al.  A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells. , 1998, Ophthalmic surgery and lasers.

[25]  C. Roberts,et al.  Pretreatment with topical diclofenac sodium to decrease postoperative inflammation. , 1996, Ophthalmology.

[26]  L. Probst,et al.  Corneal Subepithelial Infiltrates Following Photorefractive Keratectomy , 1996, Journal of cataract and refractive surgery.

[27]  P. McDonnell,et al.  Comparison of In Vitro Antiproliferative Effects of Steroids and Nonsteroidal Antiinflammatory Drugs on Human Keratocytes , 1996, Cornea.

[28]  K. Tsubota,et al.  Persistent epithelial defect following penetrating keratoplasty: an adverse effect of diclofenac eyedrops. , 1995, Cornea.

[29]  C. Roberts,et al.  A comparison of topical diclofenac with prednisolone for postcataract inflammation. , 1995, Archives of ophthalmology.

[30]  P. McDonnell,et al.  Effect of diclofenac on corneal haze after photorefractive keratectomy in rabbits. , 1995, Ophthalmology.

[31]  L. Solomon.  Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edema , 1995, Journal of cataract and refractive surgery.

[32]  R. Krueger,et al.  Role of topical corticosteroids and nonsteroidal antiinflammatory drugs in the etiology of stromal infiltrates after excimer photorefractive keratectomy. , 1994, Journal of refractive and corneal surgery.

[33]  J. Gills.  Voltaren Associated with Medication Keratitis , 1994, Journal of cataract and refractive surgery.

[34]  S. Lane,et al.  Topical diclofenac in the treatment of ocular pain after excimer photorefractive keratectomy. , 1993, Refractive & corneal surgery.

[35]  Khoa D. Nguyen,et al.  In vitro evaluation of antiproliferative potential of topical cyclooxygenase inhibitors in human Tenon's fibroblasts. , 1993, Experimental eye research.

[36]  D. Lee,et al.  Effect of steroids and nonsteroidal antiinflammatory agents on human ocular fibroblast. , 1992, Investigative ophthalmology & visual science.

[37]  L. Yannuzzi,et al.  Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. , 1991, American journal of ophthalmology.

[38]  J. A. Cameron,et al.  Risk factors for intraoperative complications in 1000 extracapsular cataract cases. , 1987, Ophthalmology.

[39]  John A. Mills.  Nonsteroidal Anti-Inflammatory Drugs , 1974 .

[40]  P. Campochiaro,et al.  Topical nepafenac inhibits ocular neovascularization. , 2003, Investigative ophthalmology & visual science.

[41]  R. Fiscella,et al.  Topical Nonsteroidal Anti-Inflammatory Drugs for Ophthalmic Use , 2002, Drug safety.

[42]  A. Flach.  Topical Nonsteroidal Antiinflammatory Drugs in Ophthalmology , 2002, International ophthalmology clinics.

[43]  T. Oshika,et al.  Comparison of diclofenac and fluorometholone in preventing cystoid macular edema after small incision cataract surgery: a multicentered prospective trial. , 2000, Japanese journal of ophthalmology.

[44]  C. Roberts.  Comparison of diclofenac sodium and flurbiprofen for inhibition of surgically induced miosis , 1996, Journal of cataract and refractive surgery.

[45]  A. Flach.  Cyclo-oxygenase inhibitors in ophthalmology. , 1992, Survey of ophthalmology.

[46]  H. Mishima,et al.  The putative role of prostaglandins in cystoid macular edema. , 1989, Progress in clinical and biological research.